These data comprehensively indicate that LSD1 inhibitor reshaped the anti‐tumoral immune microenvironment by rejuvenating of CD8+ T cells beyond merely suppressing tumour growth in vivo. The gene discussed is KDM1A; the disease is neoplasm.